As a seasoned executive, Melamud will utilise his expertise to drive global expansion, sales, and lead fundraising efforts to scale up the organisation and oversee continued research and development and commercialisation of DouxMatok’s efficient nutrition and flavour delivery technologies.
Melamud has held CEO positions with both Kimberley-Clark, the largest non-food CPG company in Israel, and most recently, Sharon Laboratories, where his role was to drive a strategic growth plan, which resulted in doubling total sales under his leadership.
Incredo Sugar is described as ‘a first-of-its-kind sugar-based sugar reduction solution and the main pillar of a full solution that includes a carefully selected mix of nutritional fibres and proteins’, that is currently available for use by food manufacturers, food service providers, co-packers, bakeries and chefs in food products.
“I’m thrilled to join the talented team of passionate professionals at DouxMatok, who are equally motivated by the inspiring mission of the company and its game changing technology,” said Melamud. “Our disruptive solution can successfully address the global challenge of overconsumption of sugar, and I’m eager to lead the company into this phase of global expansion.”
Co-founder Eran Baniel has been at the helm of DouxMatok and is responsible for having taken the company from innovative technology to commercialisation with $30m in fundraising to date and is now transitioning into an Executive Chairman role – and will continue to support the company.